Celldex Therapeutics Inc. (CLDX) Social Stream
CELLDEX THERAPEUTICS INC (CLDX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CLDX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-14 | 5 | $68 | $60 | $64.833 | $39.68 | 63.39% |
| 2022-03-01 | 6 | $68 | $60 | $64.833 | $39.68 | 63.39% |
| 2022-05-06 | 6 | $68 | $59 | $64.5 | $39.68 | 62.55% |
| 2022-08-09 | 5 | $73 | $55 | $65.2 | $39.68 | 64.31% |
| 2022-10-10 | 5 | $73 | $55 | $64.6 | $39.68 | 62.8% |
| 2023-02-27 | 6 | $73 | $55 | $64.333 | $39.68 | 62.13% |
| 2023-05-05 | 6 | $73 | $55 | $65 | $39.68 | 63.81% |
| 2023-08-09 | 6 | $73 | $54 | $63.8 | $39.68 | 60.79% |
| 2023-08-11 | 6 | $73 | $54 | $64.5 | $39.68 | 62.55% |
| 2023-10-19 | 7 | $73 | $21 | $58.285 | $39.68 | 46.89% |
| 2023-11-03 | 7 | $73 | $21 | $59.571 | $39.68 | 50.13% |
| 2023-11-04 | 7 | $73 | $21 | $59.285 | $39.68 | 49.41% |
| 2023-11-07 | 7 | $80 | $21 | $63.142 | $39.68 | 59.13% |
| 2023-11-13 | 8 | $80 | $27 | $63.285 | $39.68 | 59.49% |
The Trend in the Analyst Price Target
Over the past 37 weeks, CLDX's average price target has gone down $1.72.
Over the past 43 weeks, CLDX's average upside potential has been 96.51%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-01 | 6 | 73 | 55 | 65.000 | 46.43 | 40% |
| 2023-05-05 | 6 | 73 | 54 | 64.833 | 33.28 | 94.81% |
| 2023-06-12 | 6 | 73 | 54 | 64.833 | 37.09 | 74.8% |
| 2023-08-09 | 6 | 73 | 54 | 63.800 | 30.52 | 109.04% |
| 2023-11-03 | 7 | 73 | 21 | 59.571 | 25.98 | 129.3% |
CLDX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 7 | 0 | 0 | 1 | 1 | 8 |
The Trend in the Broker Recommendations
CLDX's average broker recommendation rating worsened by 0.57 over the prior 52 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CELLDEX THERAPEUTICS INC's variance in analysts' estimates is lower than -735.84% of all US stocks.
- CELLDEX THERAPEUTICS INC's average analyst price target is greater than 1378.49% of Pharmaceutical Products stocks.
- CELLDEX THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1232.54% of stocks in the mid market cap category.
- In terms of how CELLDEX THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 613.17% of that group.
Stocks similar to CELLDEX THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZNTL, IGMS, and KRTX.
View All Top Stocks by Price Target
Is CLDX a Buy, Hold or Sell? See the POWR Ratings now!